脂类学
代谢组学
计算生物学
甘油磷脂
脂质代谢
代谢组
生物
生物标志物
生物信息学
生物标志物发现
代谢途径
鞘脂
蛋白质组学
生物化学
癌症生物标志物
化学
嘌呤
诊断生物标志物
嘌呤代谢
磷酸胆碱
作者
Ankit Halder,Suhisna Dutta,Sridhar Epari,Prakash M. Shetty,Aliasgar V. Moiyadi,Sanjeeva Srivastava
标识
DOI:10.1021/acs.jproteome.5c00663
摘要
Meningioma, the most prevalent primary intracranial tumor, presents significant clinical challenges due to unclear molecular mechanisms underlying its progression from low-grade (LG) to high-grade (HG) and lack of grade-specific biomarkers. Here, we employed high-resolution mass spectrometry-based integrated tissue metabolomics and lipidomics on ∼45 samples. Our findings highlight dysregulated pathways like nucleotide, choline, sphingolipid, and glycerophospholipid metabolism, with purine metabolism-related metabolites notably upregulated in tumor samples. We further performed targeted verification of a subset of purine metabolism-related metabolites using targeted metabolomics. Further, serum lipidomics profiling was performed on ∼75 samples to identify a set of candidate markers. A set of lipid markers was identified as dysregulated in both tissue and serum samples, showing the effects of tumor-associated metabolic changes. The major dysregulated lipid classes were phosphatidylcholines, phosphatidylethanolamines accounting for around 70%, with variations in saturation and carbon chain length. Additionally, machine-learning-based feature selection was used to identify a panel of lipid markers capable of distinguishing HG from LG samples. This analysis identified 18 top classifier lipids, two of which were also dysregulated in tissue samples. Longitudinal analysis of these lipids further emphasized their role in tumor progression. This exploratory study lays the foundation for further validation of candidate markers in a larger cohort of samples.
科研通智能强力驱动
Strongly Powered by AbleSci AI